Sodium Chloride Injection 0.9% Medicine Infusion

Name: Sodium Chloride Injection 0.9% Medicine Infusion
Brand: Shijiazhuang No. 4 Pharmaceutical Co., Ltd.
SKU: 691518201

Hebei, ChinaShijiazhuang No. 4 Pharmaceutical Co., Ltd.

US$0.17-0.20

20,000 Pieces

Sample price:US$0.10/piece.Request sample

Product profile

Customization

Available

Application

Internal Medicine

Usage Mode

Injection

Model NO.

50ml~1000ml

Suitable for

Elderly, Adult

State

Liquid

Shape

Injection

Type

Inorganic Chemicals

Pharmaceutical Technology

Chemical Synthesis

Drug Reg./Approval No.

20023252

Transport Package

Plastic Bottle

Specification

50ml~1000ml

Trademark

SHIMEN

Origin

Hebei

HS Code

3004909099

Production Capacity

1000000

Company profile

Shijiazhuang No. 4 Pharmaceutical Co., Ltd.

Hebei, China

Business Type: Manufacturer/FactoryExport Year: 2002-01-01Nearest Port: Tianjin Xingang, Qingdao, ShanghaiAverage Response Time: ≤24hTerms of Payment: LC, T/TInternational Commercial Terms(Incoterms): FOB, CFR, CIF, CIP, EXW

AI-Powered supplier vetting

SummaryShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large, public pharmaceutical manufacturer based in Hebei, China. The company excels in producing infusion solutions and other pharmaceutical products, with advanced production lines and adherence to GMP standards. It holds ISO and GMP certifications, indicating a strong commitment to quality. The company has been exporting since 2002, with a portion of its sales derived from exports. It emphasizes innovation and customer satisfaction, with a growing reputation and numerous industry awards. However, specific details on financial credibility and customization capabilities are not fully disclosed.

Supplier typeShijiazhuang No. 4 Pharmaceutical Co., Ltd. is a large integrated pharmaceutical enterprise, engaging in manufacturing, R&D, and marketing.

CertificationsThe supplier holds ISO 9001, ISO 14001, and GMP certifications, indicating adherence to international management, environmental, and production standards.

After-Sales capabilityThe supplier emphasizes providing superior service concepts and measures, ensuring product quality and patient health.

R&D capabilityThe company integrates advanced technology into its production and emphasizes continuous improvement, indicating strong innovation capabilities.

Production capacityThe supplier has a large-scale production capacity with advanced lines for various pharmaceutical products, leading in the domestic market.